Mobile

An evaluation of the impact of early initiation of Highly Active Anti-Retroviral Therapy (HAART) on Tuberculosis (TB) treatment outcomes for TB patients co-infected with Human Immunodeficiency Virus (...

Mise à jour : Il y a 4 ans
Référence : ISRCTN77861053

An evaluation of the impact of early initiation of Highly Active Anti-Retroviral Therapy (HAART) on Tuberculosis (TB) treatment outcomes for TB patients co-infected with Human Immunodeficiency Virus (HIV)

Femme et Homme

Extrait

Not provided at time of registration

Critère d'inclusion

  • Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) co-infections

Liens